StonvexLoading…
StonvexStonvexStonvexCore line items from CRWD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 | Annual 2023 2023-01-31 |
|---|---|---|---|---|
Revenue | $4.81B | $3.95B | $3.06B | $2.24B |
Operating Income | $-293.29M | $-116.40M | $-19.14M | $-190.11M |
Net Income | $-162.50M | $-15.24M | $72.18M | $-183.25M |
EPS (Diluted) | $-0.65 | $-0.06 | $0.30 | $-0.79 |
Total Assets | $11.09B | $8.70B | $6.65B | $5.03B |
Total Liabilities | $6.61B | $5.38B | $4.31B | $3.54B |
Cash & Equivalents | $5.23B | $4.32B | $3.38B | $2.46B |
Free Cash Flow OCF − CapEx | $1.31B | $1.13B | $989.68M | $705.99M |
Shares Outstanding | 250.58M | 244.75M | 243.63M | 233.14M |